TP53 and prostate carcinoma: This is consistent with reports of less common TP53 mutations in prostate tumors from self-identified BL patients (15), since most TP53 mutations are accompanied by shallow deletions/loss of heterozygosity (LOH) of the other allele in prostate cancer (28).